The X-linked methyl binding protein gene Kaiso is highly expressed in brain but is not mutated in Rett syndrome patients

Gene

Volumn 373, Issue 1-2, 2006, Pages 83-89

  Della Ragione, Floriana ^a   Tiunova, Anna ^d   Vacca, Marcella ^a,f   Strazzullo, Maria ^a   González, Eva ^b   Armstrong, Judith ^b   Valero, Rebeca ^b   Campanile, Ciro ^a,c   Pineda, Mercè ^b   Hulten, Maj ^e   Monros, Eugenia ^b   D'Esposito, Maurizio ^a   Prokhortchouk, Egor ^g  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c CNR   (Italy)

^d P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f UNIVERSITY OF PADOVA   (Italy)

^g INSTITUTE OF BIOENGINEERING   (Russian Federation)

Author keywords

MBD family; MECP2; Mutational analysis; X chromosome; XLMR

Indexed keywords

KAISO PROTEIN; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHROMOSOME XQ; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA TEMPLATE; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HUMAN; MALE; MENTAL DEFICIENCY; MOLECULAR GENETICS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETT SYNDROME; X CHROMOSOME; ZINC FINGER MOTIF;

ANIMALS; BRAIN; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, X-LINKED; HUMANS; MALE; MICE; POLYMORPHISM, GENETIC; RETT SYNDROME; TRANSCRIPTION FACTORS;

MURINAE;

EID: 33748049116     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.01.015     Document Type: Article

References (36)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
2. Anastasiadis P.Z., and Reynolds A.B. Regulation of Rho GTPases by p120-catenin. Curr. Opin. Cell Biol. 13 (2001) 604-610
3. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 17, 434 7031 (2005) 400-404
4. Cheadle J.P., et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum. Mol. Genet. 9 (2000) 1119-1129
5. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27 (2001) 327-331
6. Chen W.G., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (2003) 885-889
7. Couvert P., et al. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 10 (2001) 941-946
8. Daniel J.M., and Reynolds A.B. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell. Biol. 19 (1999) 3614-3623
9. Daniel J.M., Spring C.M., Crawford H.C., Reynolds A.B., and Baig A. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 30 13 (2002) 2911-2919
10. Depledge D.P., and Dalby A.R. COPASAAR-a database for proteomic analysis of single amino acid repeats. BMC Bioinformatics 6 196 (2005)
11. Engerstrom I.W., and Kerr A. Rett Disorder and the Developing Brain (2001), Oxford University Press
12. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), San Diego Academic Press
13. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27 (2001) 322-326
14. Horike S., Cai S., Miyano M., Cheng J.F., and Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37 (2005) 31-40
15. Jones P.L., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19 (1998) 187-191
16. Karlin S., Brocchieri L., Bergman A., Mrazek J., and Gentles A.J. Amino acid runs in eukaryotic proteomes and disease associations. Proc. Natl. Acad. Sci. U. S. A. 99 1 (2002) 333-338
17. Kerr A.M. Rett syndrome British Longitudinal study (1982-1990) and 1990 survey. Mental Retardation and Medical Care. April 21-24. Uitgeverij Kerckbosch ed JJ Rosendaal Zeist (1991) 143-145
18. Klose R.J., Sarraf S.A., Schmiedeberg L., McDermott S.M., Stancheva I., and Bird A.P. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19 (2005) 667-678
19. Laccone F., et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Human Mutat. 23 (2004) 234-244
20. Mari F., et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early seizure variant of Rett Syndrome. Hum. Mol. Genet. 14 14 (2005) 1935-1946
21. Martinowich K., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 (2003) 890-893
22. Meloni I., et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am. J. Hum. Genet. 67 (2000) 982-985
23. Nan X., et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
24. Orrico A., et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 481 (2000) 285-288
25. Park J.I., et al. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev. Cell 8 6 (2005) 795-796
26. Prokhortchouk A., et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15 (2001) 1613-1618
27. Prokhortchouk A., et al. Kaiso-deficient mice show resistance to intestinal cancer. Mol. Cell. Biol. 26 (2006) 199-208
28. Ropers H.H., and Hamel B.C. X-linked mental retardation. Nat. Rev., Genet. 6 (2005) 46-57
29. Stancheva I., Collins A.L., Van den Veyver I.B., Zoghbi H., and Meehan R.R. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell 12 (2003) 425-435
30. Tao J., et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am. J. Hum. Genet. 75 (2004) 1149-1154
31. Vacca M., et al. MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved region. Brain Dev. 23 Suppl 1 (2001) S246-S250
32. Vacca M., et al. Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J. Mol. Med. 78 (2001) 648-655
33. Wan M., et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am. J. Hum. Genet. 65 (1999) 1520-1529
34. Weaving L.S., et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75 (2004) 1079-1093
35. Weaving L.S., Ellaway C.J., Gecz J., and Christodoulou J. Rett syndrome: clinical review and genetic update. J. Med. Genet. 42 (2005) 1-7
36. Yoon H.G., Chan D.W., Reynolds A.B., Qin J., and Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12 (2003) 723-734